| Home > Authorities > Institutes > Record #144946 |
TU02
DKTK TU Translationale Immunologie| ID | I:(DE-He78)TU02-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
„First-in-human“-Studie mit dem Antikörper CC-1 beim CRPC
Aktuelle Urologie 57(03), 250 - 252 (2026) [10.1055/a-2841-6607]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Editorial)
„First-in-human“-Studie mit dem Antikörper CC-3 beim Peniskarzinom
Aktuelle Urologie 57(03), 248 - 249 (2026) [10.1055/a-2703-9949]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Mouse TAPBPR shows functional similarity to human TAPBPR in shaping the MHC-I immunopeptidome.
Frontiers in immunology 17, 1756668 (2026) [10.3389/fimmu.2026.1756668]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19.
Clinical therapeutics 48(3), 232-239 (2026) [10.1016/j.clinthera.2026.01.004]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma.
Journal of translational medicine 24(1), 1204 (2026) [10.1186/s12967-026-09000-5]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Loss of BECN1 does not compromise autophagosome formation but alters cargo selection and HLA-restricted antigen presentation of B cells.
Autophagy nn, nn (2026) [10.1080/15548627.2026.2719432]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Identification of novel HLA class I-restricted hepatitis B virus peptides and their modulation by peptide editor TAPBPR.
Frontiers in immunology 17, 1892820 (2026) [10.3389/fimmu.2026.1892820]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
The challenge of patient recruitment into early phase clinical trials: Is time-effective academic translational research feasible? Lessons from a phase I/II trial in patients with B-cell deficiencies.
Frontiers in medicine 13, 1844041 (2026) [10.3389/fmed.2026.1844041]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Characterization of TROP-2 bispecific T cell engagers for immunotherapy of triple negative breast and bladder cancer.
Frontiers in immunology 17, 1794705 (2026) [10.3389/fimmu.2026.1794705]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia.
Frontiers in immunology 17, 1728424 (2026) [10.3389/fimmu.2026.1728424]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |